Selective Laser Trabeculoplasty (SLT) Complicated by Intraocular Pressure Elevation in Eyes With Heavily Pigmented Trabecular Meshworks - 18/08/11
, Demosthenes G. Papamatheakis, MD a, Mark Latina, MD b, Mark De Leon, MD c, Mark R. Lesk, MD, MSc a, Karim F. Damji, MD d
Inquiries to Paul Harasymowycz, MD, Department of Ophthalmology, Maisonneuve-Rosemont Hospital, 5689 Boulevard Rosemont, Montreal, Quebec, Canada, H1T 2H1; fax: (514) 252-3905;Résumé |
Purpose |
To report and assess the complication of intraocular pressure (IOP) elevations after selective laser trabeculoplasty (SLT) in patients with heavily pigmented trabecular meshworks.
Design |
Noncomparative, observational case series.
Methods |
Retrospective analysis of the medical files of four glaucoma patients with heavily pigmented trabecular meshwork, who presented with IOP elevations after SLT.
Results |
All four glaucoma patients presented with post-SLT IOP elevations. Three had features of pigmentary dispersion syndrome, and the fourth had a heavily pigmented trabecular meshwork. Two patients had previous argon laser trabeculoplasty (ALT) in the same eye in which SLT was performed, and one had a previous ocular trauma. Eventually, three of the patients required surgical trabeculectomy.
Conclusions |
This case series suggests that post-SLT IOP elevations can be a serious adverse event in some glaucomatous patients. It is recommended by the authors that patients with a deeply pigmented trabecular meshwork, taking multiple topical medications and having previous ALT treatment, should be considered at higher risk for this complication.
Le texte complet de cet article est disponible en PDF.| Dr. Latina is a patent holder of SLT and has a financial interest with Lumenis. |
Vol 139 - N° 6
P. 1110-1113 - juin 2005 Retour au numéro
Article précédent
- Combined Esterified Estrogen and Methyltestosterone Treatment for Dry Eye Syndrome in Postmenopausal Women
- Garrett Scott, Samuel C. Yiu, Daniel Wasilewski, Jonathan Song, Ronald E. Smith
- Total Blindness From Presumed Optic Nerve Melanocytoma
- Jerry A.. Shields, Carol L. Shields, Hormoz Ehya, Ranjit S. Dhaliwal
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?